Research‎ > ‎

Safety of Medications

KOREN, G., MALTEPE, C., & GOW, R., 2011 Therapeutic Choices for Nausea and Vomiting of Pregnancy: A Critical Review of a Systematic Review Journal of Obstetrics and Gynaecology 33(7): 733-735 Koren 2011 Therapeutic Choices NVP critical review

EINARSON, A., MALTEPE, C., NAVIOZ, Y., KENNEDY, D., TAN, M. P. & KOREN, G. 2004. The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. Bjog-an International Journal of Obstetrics and Gynaecology, 111, 940-943. EINARSON 2004 Safety ondansetron in pregnancy

GILL, S, K., O'BRIEN, L. & KOREN, G. 2009 The safety of Histamine 2 (H2) Blockers in Pregnancy: A Meta Analysis. Digestive Diseases and Sciences 54 (9) 1835-38 GILL 2009 Safety Histamine 2 Pregnancy

GILL, S, K., EINARSON, A. 2007 The safety of drugs for the treatment of nausea and vomiting of pregnancy Expert Opinion on Drug Safety 6(6) 685-694 GILL 2011 Safety of drugs for NVP

GILL, S, K., O'BRIEN, L. & KOREN, G., EINARSON, T.R. 2009 The Safety of Proton Pump Inhibitors (PPIs) in Pregnancy: A Meta-Analysis American Journal of Gastroenterology 104(6) 1541-45 GILL 2009 Safety PPI Pregnancy Meta Analysis

KOREN, G. & LEVICHEK, Z., 2002 The teratogenicity of drugs for nausea and vomiting of pregnancy: Perceived versus true risk American Journal of Obstetrics and Gynaecology 186 (5) S248-S252 KOREN 2002 Teratogenicity drugs NVP perceived v true risk

MATOK, I., GORODISCHER, R., KOREN, G., SHEINER, E., WIZNITZER, A, & LEVY, A. 2009 The Safety of Metoclopramide Use in the First Trimester of Pregnancy EDITORIAL COMMENT Obstetrical & Gynaecological Survey 64(10) 637-638 MATOK 2009 Safety Metoclopramide Pregnancy

PASTERNAK, B. & HVIID, A. 2010 Use of Proton-Pump Inhibitors in Early Pregnancy and the Risk of Birth Defects New England Journal of Medicine 363 (22) 2114-23 PASTERNAK 2010 PPI Pregnancy Birth Defect

ASKER, C., WIKNER, B.N. & KALLEN, B. 2005 Use of antiemetic drugs during pregnancy in Sweden European Journal of Clinical Pharmacology 61 (12) 899-906 ASKER 2005 Antiemetics use pregnancy Sweden

PASTERNAK, B. 2013 Ondansetron in pregnancy and risk of adverse fetal outcomes  New England Journal of Medicine Pasternak NEJM

Illinois Teratogen Information Service http://fetal-exposure.org/. This site provides summaries pf safety in pregnancy data for a wide range of substances. The factsheet for medications used to treat nausea and vomiting in pregnancy can be seen in Documents